Kallmann Syndrome
Description
Kallmann syndrome (KS) is a developmental genetic disorder characterized by the association of congenital hypogonadotropic hypogonadism (CHH) due to gonadotropin-releasing hormone (GnRH) deficiency, and anosmia or hyposmia (with hypoplasia or aplasia of the olfactory bulbs).
Genes related to Kallmann Syndrome
- FGF8
- CHD7
- HESX1
- FGFR1
- DCC
- KISS1R
- PROK2
- TACR3
- NSMF
- FLRT3
- SOX10
- FGF17
- HS6ST1
- SPRY4
- DUSP6
- FEZF1
- IL17RD
- CCDC141
- PROKR2
- WDR11
- SEMA3A
- ANOS1
Clinical Features
Top most frequent phenotypes and symptoms related to Kallmann Syndrome
- Seizures
- Ataxia
- Nystagmus
- Sensorineural hearing impairment
- Muscle weakness
- Muscular hypotonia
- Cleft palate
- Cryptorchidism
- Ptosis
- Visual impairment
And another 34 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available KALLMANN SYNDROME have a estimated prevalence of 3.75 per 100k worldwide.— No data available about the known clinical features onset.
Alternative names
Kallmann Syndrome Is also known as congenital hypogonadotropic hypogonadism with anosmia, olfacto-genital pathological sequence.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Kallmann Syndrome Recommended genes panels
| Panel Name, Specifity and genes Tested/covered |
|---|
 FGF8 DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
FGF8
Specificity
100 %
Genes
5 % |
|
Anosmic Kallmann/IHH Evaluation.
By Athena Diagnostics Inc (United States).
PROKR2, PROK2, FGF8, FGFR1, GNRHR, KISS1R, ANOS1
Specificity
86 %
Genes
28 % |
|
Complete Kallmann/IHH Evaluation.
By Athena Diagnostics Inc (United States).
TACR3, PROKR2, PROK2, CHD7, FGF8, FGFR1, GNRH1, GNRHR, KISS1R, ANOS1
Specificity
80 %
Genes
37 % |
|
Comprehensive Brain Malformation Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SHH, STIL, SIX3, SLC9A6, SOX2, CDKL5, TGIF1, MED12, CEP41, TUBA8, UBE3A, VLDLR, VRK1, ZIC2, ACTB, MRPS16, NSD1, RAB18, ACTG1, SLC25A19 , (...)
View the complete list with 86 more genes
Specificity
2 %
Genes
10 % |
|
Holoprosencephaly.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SHH, SIX3, TGIF1, ZIC2, CDON, DISP1, DLL1, FGF8, FOXH1, GAS1, GLI2, NODAL, PTCH1
Specificity
8 %
Genes
5 % |
|
Hypogonadotropic Hypogonadism Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
TAC3, TACR3, WDR11, PROKR2, IL17RD, PROK2, CHD7, FEZF1, NSMF, FGF17, FGF8, FGFR1, FSHB, GNRH1, GNRHR, KISS1R, ANOS1, LHB, NR0B1
Specificity
69 %
Genes
60 % |
|
Holoprosencephaly Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
SHH, STIL, SIX3, TGIF1, ZIC2, CDON, FGF8, FGFR1, GLI2, PTCH1
Specificity
20 %
Genes
10 % |
|
Holoprosencephaly Deletion/Duplication Panel.
By Genetic Services Laboratory University of Chicago (United States).
SHH, STIL, SIX3, TGIF1, ZIC2, CDON, FGF8, FGFR1, GLI2, PTCH1
Specificity
20 %
Genes
10 % |
You can get up to 555 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like POLYCYSTIC OVARY SYNDROME 1; PCOS1 LEBER CONGENITAL AMAUROSIS 11; LCA11 JOUBERT SYNDROME 10; JBTS10